Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France registry.

MLA

Moulis, Guillaume, et al. “Difficult‐to‐treat Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the CARMEN‐France Registry.” British Journal of Haematology, vol. 204, no. 4, Apr. 2024, pp. 1476–82. EBSCOhost, https://doi.org/10.1111/bjh.19288.

APA

Moulis, G., Rueter, M., Duvivier, A., Mahévas, M., Viallard, J., Comont, T., Chèze, S., Audia, S., Ebbo, M., Terriou, L., Lega, J., Jeandel, P., Hemim, I., Bozzi, S., Daak, A., Okada, H., Bonnotte, B., Michel, M., Lapeyre, M. M., & Godeau, B. (2024). Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France registry. British Journal of Haematology, 204(4), 1476–1482. https://doi.org/10.1111/bjh.19288

Chicago

Moulis, Guillaume, Manuela Rueter, Aymeric Duvivier, Matthieu Mahévas, Jean‐François Viallard, Thibault Comont, Stéphane Chèze, et al. 2024. “Difficult‐to‐treat Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the CARMEN‐France Registry.” British Journal of Haematology 204 (4): 1476–82. doi:10.1111/bjh.19288.